MedPage Today: Taking a Hard Look at Splenectomy in the Management of Splenic Lymphoma —Before making a decision about splenectomy, get a thorough hematopathology review of available diagnostic material—and advice from a lymphoma specialist. Reviewed by Chaitra Ujjani, MD, Associate ... Taking a Hard Look at Splenectomy in the Management of Splenic Lymphoma THIS communication presents the results of splenectomy performed in patients with various blood dyscrasias who have been followed in the Blood Clinic of the New England Medical Center during the past ...

Understanding the Context

What treatment guidelines should the primary care clinician follow for a patient who has had a splenectomy? I have a 40-year-old patient who lost her spleen following a MVA at 18 years of age. Before ... The New England Journal of Medicine: Splenectomy for Myeloid Metaplasia of the Spleen We have had the opportunity to study 5 patients with "agnogenic myeloid metaplasia" who were subjected to splenectomy.

Key Insights

In no case was there any apparent deleterious effect, and 1 patient was obviously ... “It appears that, at least for MCL and SMZL, splenectomy has largely gone away as a diagnostic or therapeutic modality… We do [splenectomies] often for difficult cases, thus avoiding many surgeries, ... The American Journal of Managed Care: Splenectomy Before Stem Cell Transplant May Help Certain Patients With MF Splenectomy before allogeneic hematopoietic stem cell transplantation (alloHSCT) might be a promising option in patients with myelofibrosis (MF) who failed to achieve significant spleen response after ... 1. Which doctor does splenectomy?

Final Thoughts

The splenectomy surgery is usually done by a general surgeon who is familiar with the procedure. 2. How can you live without a spleen? Though the spleen is important, ... ascopubs.org: Interaction of Splenectomy and Perioperative Blood Transfusions on Prognosis of Patients With Proximal Gastric and Gastroesophageal Junction Cancer Interaction of Splenectomy and Perioperative Blood Transfusions on Prognosis of Patients With Proximal Gastric and Gastroesophageal Junction Cancer